Abbott to deal pharma line to Mylan for $5.3B

Abbott agrees to deal its specialty and branded generic pharmaceutical line to Mylan for $5.3 billion.

Mylan Inc., Abbott Laboratories

News Well, Mergers & Acquisitions, Pharmaceuticals, Wall Street Beat

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1qadSaE